BIDMC’s Adam Rodman, MD, MPH, Named to National Academy of Medicine’s 2026 Class of Scholars in Diagnostic Excellence
National Academy of Medicine Selects Adam Rodman, MD, MPH, for 2026 Diagnostic Excellence Scholars Program
BOSTON — Adam Rodman, MD, MPH, is among the 10 individuals selected by the National Academy of Medicine (NAM) for its 2026 class of the NAM Scholars in Diagnostic Excellence program.
Rodman, who is director of AI programs for BIDMC’s Carl J. Shapiro Institute for Education and Research, and his fellow 2026 scholars were chosen based on their professional qualifications and accomplishments, demonstrated leadership in the field, and potential to advance diagnostic excellence. The selection process also weighed program proposals’ quality and feasibility to improve diagnosis and reduce diagnostic errors at the national level, building on the National Academies’ 2015 consensus report, Improving Diagnosis in Health Care.
Rodman’s program, “Laying the Groundwork for an Effective, Evidence-Grounded LLM-Based Second Opinion Trigger System for High-Risk Hospitalized Inpatients,” will focus on understanding the human factors that allow AI second opinions to impact clinical care positively. Rodman will lead an early-stage clinical trial at BIDMC as part of this project.
"The National Academy of Medicine has worked tirelessly to help improve diagnosis, and to protect patient safety,” Rodman said. “I'm incredibly honored that my work to understand the diagnostic capabilities of AI will benefit from their expertise."
A collaborative effort with the Council of Medical Specialty Societies (CMSS), the NAM Scholars in Diagnostic Excellence program offers a one-year, part-time experience for exceptional health professionals to advance their diagnostic skills, make significant contributions to improve clinical diagnosis at the national level, and accelerate their career development as national leaders in the field.
The scholars will continue in their primary posts while engaging part time over a one-year period in developing an implementation plan for their proposals, as well as participating in monthly educational sessions, cohort learning activities, and professional networking opportunities through the NAM and CMSS. In addition, each scholar will be matched with a mentor or mentors who can provide professional guidance and subject matter or technical expertise for their work. A flexible research grant will be awarded to every scholar.
Funding for the program is provided by the Gordon and Betty Moore Foundation, with additional support from the Coordinating Center for Diagnostic Excellence (CODEX) at the University of California, San Francisco.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a leading academic medical center, where extraordinary care is supported by high-quality education and research. BIDMC is a teaching affiliate of Harvard Medical School, and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Beth Israel Deaconess Medical Center is a part of Beth Israel Lahey Health, a healthcare system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,700 physicians and 39,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.
